Generic Effient

There are currently no generic versions of Effient (prasugrel). Although the first patent for the brand-name version is set to expire in 2012, Eli Lilly and Company has exclusive rights to make the drug in the United States until at least July 2014. Even though prasugrel is the active ingredient in Effient, it is not the same as a generic version of the drug.

Can I Buy Generic Effient?

Effient® (prasugrel hydrochloride) is a prescription antiplatelet medication used to prevent strokes, heart attacks, and cardiovascular-related deaths (due to heart attacks or strokes) in people who have had an angioplasty procedure to treat a blocked coronary artery after experiencing a heart attack or heart-related chest pains.
 
Effient is manufactured by Eli Lilly and Company, and is marketed by Daiichi Sankyo, Inc., and Eli Lilly and Company. No generic versions of Effient are available at this time.
 

When Will a Generic Version Be Available?

The first patent for Effient is currently set to expire in September 2012, although Eli Lilly and Company holds the exclusive rights to make this drug in the United States until at least July 2014. This is the earliest predictable date that a generic version of Effient could become available.
 
However, other circumstances could come up to extend or shorten this exclusivity period. This could include such things as lawsuits or other patents for specific Effient uses. It is usually quite difficult to predict exactly when a generic version of any medication may become available.
 

Is Prasugrel a Generic Effient?

No -- prasugrel is the active ingredient in Effient, but is not a generic version of it.
 What can be confusing is that oftentimes, the active ingredient of any drug is referred to as the "generic name."
 
The generic name is different from a generic version of a medicine. In order for there to be a generic version of a medicine, the original medicine must have gone off-patent and another company besides the original manufacturer must make the product.
 
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD
Other Articles in This eMedTV Presentation